Welcome to our dedicated page for Ensign Group SEC filings (Ticker: ENSG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ensign Group’s dual identity as a post-acute care operator and real-estate lessor makes its SEC disclosures notoriously dense. Medicaid rate shifts, lease covenants, and facility occupancy tables create a maze for analysts who simply want to know, “How is the skilled nursing segment really performing?” Stock Titan eliminates that struggle with AI-powered summaries that turn 300-page documents into crisp insights you can absorb in minutes.
Need the latest Ensign Group quarterly earnings report 10-Q filing? It’s here, alongside an AI note that highlights reimbursement exposure by state. Curious about Ensign Group insider trading Form 4 transactions or Ensign Group Form 4 insider transactions real-time? Our platform streams them seconds after they hit EDGAR, complete with trend graphs that flag unusual buying by facility leaders. For every 8-K, you’ll see “Ensign Group 8-K material events explained” so you know exactly why a new lease or acquisition matters. And if you’re preparing deep research, the Ensign Group annual report 10-K simplified section links directly to AI-generated breakouts of segment margins, census trends, and Standard Bearer rental income.
Investors use these tools to compare quarter-over-quarter revenue, monitor Ensign Group executive stock transactions Form 4, or drill into Ensign Group proxy statement executive compensation without wading through footnotes. With real-time filing alerts, comprehensive coverage of every form, and expert analysis that translates healthcare jargon, understanding Ensign Group SEC documents with AI becomes effortless. Save hours, spot risks early, and act on data instead of digging for it—Stock Titan has already done the heavy lifting.
The Ensign Group, Inc. (ENSG) Form 144 notice reports a proposed sale of 1,000 common shares through Fidelity Brokerage Services with an aggregate market value of $166,170.00, scheduled approximately 08/15/2025 on NASDAQ. The shares were acquired via restricted stock vesting on various dates (2018 and 2025) and paid as compensation. The filer disclosed prior sales of 1,999 shares on 05/15/2025 generating $290,794.53. The notice includes the required attestation about material nonpublic information.
The Ensign Group, Inc. insider disclosed an option exercise and immediate sale by CEO and director Barry Port. The reporting person exercised 2,399 employee stock options with a $15.93 exercise price and sold 2,399 shares at $160 per share on 08/08/2025 under a Rule 10b5-1 trading plan adopted May 6, 2024.
The report shows the reporting persons direct beneficial ownership after the transactions as 57,030 shares and indirect beneficial ownership of 155,300 shares held of record by trusts for Barry R. Port and spouse Michelle Port. The underlying options were granted August 31, 2016 and vested over five equal annual installments.
The filing is a Form 144 for The Ensign Group, Inc. (ENSG) disclosing a proposed sale of 2,399 common shares. The seller intends to execute the transaction through Fidelity Brokerage Services LLC on or about 08/08/2025. Based on the filing, the shares carry an aggregate market value of $383,840, while the company has 57,700,157 shares outstanding. The securities were originally obtained via an employee stock option granted on 08/31/2016 and will be purchased for cash at exercise on the transaction date. No other sales by this individual occurred within the last three months. The notice affirms that the filer possesses no undisclosed material adverse information about the issuer.
The Ensign Group, Inc. (ENSG) filed Form 144 disclosing a planned sale of 425 common shares through Fidelity Brokerage Services LLC, expected on or after 31 Jul 2025. The shares have an estimated aggregate market value of $63,422.75 and represent an immaterial ~0.0007 % of the company’s 57.7 million shares outstanding.
The securities were originally received as restricted-stock vesting awards on 15 Jan 2021 (260 sh) and 15 Jul 2021 (165 sh) as compensation from the issuer. The filer reports no sales in the prior three months. Given the small size and routine nature of the transaction, the notice is unlikely to have a meaningful impact on ENSG’s share price but does signal a minor insider disposition.
FAQ
What is the current stock price of Ensign Group (ENSG)?
What is the market cap of Ensign Group (ENSG)?
